Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,497
Closed -$211K 74
2026
Q1
$211K Buy
+7,497
New +$200K 0.08% 73
2025
Q3
Sell
-2,518,659
Closed -$61.1M 780
2025
Q2
$61.1M Buy
2,518,659
+296,001
+13% +$6.9M 0.18% 123
2025
Q1
$56.3M Buy
2,222,658
+3,784
+0.2% +$99K 0.19% 113
2024
Q4
$58.9M Sell
2,218,874
-8,387
-0.4% -$227K 0.18% 112
2024
Q3
$64.5M Sell
2,227,261
-405,119
-15% -$11.8M 0.19% 111
2024
Q2
$73.7M Buy
2,632,380
+123,605
+5% +$3.4M 0.22% 101
2024
Q1
$69.6M Buy
2,508,775
+312,859
+14% +$8.68M 0.21% 107
2023
Q4
$63.2M Buy
2,195,916
+419,992
+24% +$12.7M 0.2% 117
2023
Q3
$58.9M Sell
1,775,924
-33,683
-2% -$1.19M 0.21% 115
2023
Q2
$66.4M Sell
1,809,607
-1,482,990
-45% -$57.7M 0.22% 107
2023
Q1
$134M Buy
3,292,597
+389,471
+13% +$16.8M 0.46% 40
2022
Q4
$149M Buy
2,903,126
+1,189,086
+69% +$57M 0.54% 33
2022
Q3
$75M Sell
1,714,040
-205,904
-11% -$10M 0.3% 83
2022
Q2
$101M Sell
1,919,944
-342,155
-15% -$17.4M 0.37% 64
2022
Q1
$117M Buy
2,262,099
+1,228,765
+119% +$63.8M 0.33% 69
2021
Q4
$61M Sell
1,033,334
-538,928
-34% -$26.7M 0.16% 160
2021
Q3
$67.6M Sell
1,572,262
-52,327
-3% -$2.32M 0.19% 138
2021
Q2
$63.6M Sell
1,624,589
-92,063
-5% -$3.58M 0.18% 140
2021
Q1
$62.2M Sell
1,716,652
-742,888
-30% -$26.4M 0.19% 129
2020
Q4
$90.5M Sell
2,459,540
-807,763
-25% -$29.6M 0.28% 78
2020
Q3
$114M Sell
3,267,303
-1,682,324
-34% -$59M 0.41% 49
2020
Q2
$154M Buy
4,949,627
+417,816
+9% +$14.2M 0.61% 27
2020
Q1
$140M Sell
4,531,811
-136,857
-3% -$4.66M 0.7% 22
2019
Q4
$174M Buy
4,668,668
+1,864,795
+67% +$66.4M 0.71% 20
2019
Q3
$95.6M Buy
2,803,873
+35,870
+1% +$1.3M 0.38% 56
2019
Q2
$114M Buy
2,768,003
+181,626
+7% +$7.21M 0.44% 43
2019
Q1
$104M Buy
2,586,377
+267,592
+12% +$10.7M 0.41% 48
2018
Q4
$96M Sell
2,318,785
-175,022
-7% -$7.27M 0.42% 47
2018
Q3
$104M Buy
2,493,807
+157,327
+7% +$6.06M 0.38% 56
2018
Q2
$80.4M Sell
2,336,480
-857,213
-27% -$29.3M 0.31% 83
2018
Q1
$108M Sell
3,193,693
-2,274,936
-42% -$78.2M 0.43% 55
2017
Q4
$188M Buy
5,468,629
+461,694
+9% +$15.7M 0.74% 17
2017
Q3
$170M Sell
5,006,935
-140,703
-3% -$4.52M 0.73% 16
2017
Q2
$164M Buy
5,147,638
+164,683
+3% +$5.19M 0.74% 19
2017
Q1
$162M Sell
4,982,955
-1,820,225
-27% -$57.4M 0.73% 22
2016
Q4
$210M Sell
6,803,180
-1,023,214
-13% -$31.2M 0.98% 7
2016
Q3
$251M Buy
7,826,394
+767,133
+11% +$25.7M 1.1% 6
2016
Q2
$236M Sell
7,059,261
-1,616,079
-19% -$51.6M 1.05% 8
2016
Q1
$244M Sell
8,675,340
-87,026
-1% -$2.49M 1.09% 5
2015
Q4
$268M Sell
8,762,366
-1,491,696
-15% -$46.9M 1.17% 5
2015
Q3
$306M Sell
10,254,062
-874,122
-8% -$28M 1.25% 9
2015
Q2
$354M Sell
11,128,184
-500,386
-4% -$16.3M 1.42% 5
2015
Q1
$384M Sell
11,628,570
-355,822
-3% -$11.3M 1.58% 4
2014
Q4
$354M Sell
11,984,392
-72,278
-0.6% -$2.07M 1.42% 4
2014
Q3
$338M Buy
12,056,670
+50,502
+0.4% +$1.42M 1.45% 5
2014
Q2
$338M Buy
12,006,168
+9,927
+0.1% +$283K 1.41% 3
2014
Q1
$366M Sell
11,996,241
-513,606
-4% -$15.3M 1.59% 4
2013
Q4
$364M Sell
12,509,847
-293,347
-2% -$8.54M 1.63% 3
2013
Q3
$349M Sell
12,803,194
-49,333
-0.4% -$1.34M 1.72% 2
2013
Q2
$342M Buy
+12,852,527
New +$355M 1.81% 1

Other funds holding PFE

Axa's PFE Position: Q2 2026 in Review

Axa sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,497 shares — an estimated $211K sold.

Axa first reported a position in PFE in Q2 2013 and held it in 50 quarters. The position peaked at $384M in Q1 2015. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Axa reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Axa sold 7,497 Pfizer shares in Q2 2026, an estimated $211K.
  • Axa first reported a position in Pfizer in Q2 2013 and held it in 50 quarters.
  • Axa's Pfizer position peaked at $384M in Q1 2015.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Axa's 13F filing for Q2 2026, filed 14 Aug 2026.